Regeneron Reports Strong Growth and Promising Pipeline
at www.tipranks.com (Tue, 4-Feb 7:10 PM)
Regeneron Stock: Buy Rating Backed by Robust Growth Prospects and Strategic Financial Moves
at www.tipranks.com (Tue, 4-Feb 2:25 PM)
Why Selling This Iron Condor Spread in REGN Makes Sense for a $17.4 Credit
Market Chameleon (Tue, 4-Feb 12:06 PM)
at www.benzinga.com (Tue, 4-Feb 12:02 PM)
Regeneron projects EYLEA HD growth with new approvals and prefilled syringe launch in 2025
at seekingalpha.com (Tue, 4-Feb 11:34 AM)
Regeneron's new dividend, Dupixent growth support strong Q4
at seekingalpha.com (Tue, 4-Feb 10:27 AM)
Regeneron Pharmaceuticals declares its first-ever dividend of $0.88, announces $3.0B buyback
at seekingalpha.com (Tue, 4-Feb 6:50 AM)
Regeneron Pharmaceuticals beats top-line and bottom-line estimates; initiates FY25 outlook
at seekingalpha.com (Tue, 4-Feb 6:33 AM)
Here's the major earnings before the open tomorrow
at seekingalpha.com (Mon, 3-Feb 6:00 PM)
Regeneron Pharmaceuticals Q4 2024 Earnings Preview
at seekingalpha.com (Mon, 3-Feb 2:28 PM)
Earnings week ahead: PLTR, AMZN, GOOG, AMD, LLY, PEP, F, PFE, MRK, PYPL and more
at seekingalpha.com (Sun, 2-Feb 8:00 AM)
Regeneron: Strong Buy Rating Driven by Dupixent’s Growth and Promising Pipeline Developments
at www.tipranks.com (Thu, 30-Jan 6:27 AM)